Early Anti-inflammatory Treatment in Patients With Acute ACL Tear and Painful Effusions

ClinicalTrials.gov ID: NCT03429140

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03429140. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is designed to allow the investigator to answer many questions about the reasons why anterior cruciate ligament (ACL) injury leads to knee pain and disability and osteoarthritis. The purpose of this research is to gather information on how safe and effective Gel-One is in alleviating knee pain following ACL surgery.

Study identification

NCT ID: NCT03429140
Recruitment status: Completed
Study type: Interventional
Phase: Early Phase 1
Lead sponsor: Cale Jacobs, PhD; Other
Enrollment: 24 participants

Conditions and interventions

Conditions

Anterior Cruciate Ligament

Interventions

Gel-One Drug
Saline Placebo Other

Drug · Other

Eligibility (public fields only)

Age range: 14 Years to 33 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 6, 2017 (Actual)
Primary completion: Jun 23, 2019 (Actual)
Completion: Jun 23, 2019 (Actual)
Last update posted: Sep 13, 2022

2017 – 2019

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
UK Healthcare at Turfland	Lexington	Kentucky	40504	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03429140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 13, 2022 · Synced Nov 12, 2026